Korean botox brands compared 2026: Nabota vs Meditoxin vs Bocouture pricing guide

Key numbers

Nabota received FDA approval in the US in 2019 under brand name Jeuveau, with global sales of $248 million in 2024 (Daewoong Pharmaceuticals 2024 annual report)

Seoul 2026 pricing per unit: Nabota $5–8, Meditoxin $4–7, Bocouture $8–12, Allergan Botox (imported) $10–14

Typical treatment amounts: forehead 10–20 units, glabella 15–25 units, crow's feet 10–15 units per side, masseter (jaw slimming) 30–50 units per side

Korean botulinum toxin exports totaled $685 million in 2024, a 24% increase from 2023 (Korea Customs Service)

A 2023 comparative clinical study of 300 patients found Nabota and Allergan Botox produced statistically equivalent glabella line reduction at 4 weeks post-injection (Aesthetic Plastic Surgery Journal)

Approximately 1–3% of long-term botox users develop neutralizing antibodies over time, making 'clean' formulations like Bocouture preferred for patients with planned long-term treatment (American Society of Plastic Surgeons)

Korea produces four major botulinum toxin type A brands: Nabota (Daewoong), Meditoxin (Medytox), Jetema, and imports Bocouture (Merz) and Allergan Botox. Choosing between them affects results, longevity, and cost significantly.

Nabota is Korea's most-exported botulinum toxin and is FDA-approved in the US as 'Jeuveau.' Clinical studies consistently show Nabota equivalent efficacy to Allergan Botox for glabella and frontalis indications.

Meditoxin has a complicated history — license temporarily suspended 2020–2023 over manufacturing documentation issues, now fully restored. It remains a cost-effective option at Korean clinics but foreign patients often prefer Nabota for regulatory familiarity.

Bocouture is the premium choice — German-manufactured with no complexing proteins, reducing the risk of neutralizing antibody formation. Preferred by celebrities and long-term botox users. Price reflects the premium.

Korearly does not provide medical advice. Verify product sealed vials in front of you at any clinic — diluted or black-market botulinum toxin remains a real risk at discount clinics.

Frequently asked questions

Which Korean botox is safest?

All MFDS-approved Korean botulinum toxins are safe when administered by licensed professionals with authentic sealed product. Nabota has the most international regulatory validation (FDA-approved). Bocouture's 'clean' formulation reduces long-term antibody risk.

How long does Korean botox last?

3–4 months for dynamic line areas (forehead, glabella, crow's feet). 4–6 months for masseter (jaw slimming) due to larger dose. Individual metabolism varies — frequent exercisers may see shorter duration.

Is Korean botox cheaper than US botox?

Yes, significantly. Seoul per-unit prices are 50–70% lower than US Allergan Botox prices. For foreign patients, this offsets travel costs if multiple areas are treated.

Can I combine Korean botox with Juvelook or Rejuran?

Yes. Standard sequencing: Rejuran or Juvelook first (structural/regenerative), then Botox (anti-dynamic) in the same session if clinic scheduling allows, or 2 weeks apart.

What if my face looks frozen after Korean botox?

'Frozen' expression is a dosing issue, not a brand issue. Top Seoul dermatology clinics use 'baby botox' protocols — smaller, well-distributed doses that preserve expression while softening lines. Request this approach explicitly at consultation.

Can foreigners get Korean botox without a medical visa?

Yes, botulinum toxin injection is considered a minor outpatient procedure. Most Western passport holders can enter Korea under 90-day visa-free tourism. However, if you're doing multiple procedures during a stay longer than 90 days, a medical e-visa (C-3-3) is required.